Citation: It. Gram et al., Reversal of gonadotropin-releasing hormone agonist induced reductions in mammographic densities on stopping treatment, CANC EPID B, 10(11), 2001, pp. 1117-1120
Authors:
McKean-Cowdin, R
Feigelson, HS
Pike, MC
Coetzee, GA
Kolonel, LN
Henderson, BE
Citation: R. Mckean-cowdin et al., Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype, CANCER RES, 61(3), 2001, pp. 848-849
Authors:
Ross, RK
Paganini-Hill, A
Wan, PC
Pike, MC
Citation: Rk. Ross et al., Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin, J NAT CANC, 92(4), 2000, pp. 328-332
Citation: Mc. Pike et Rk. Ross, Re: Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin - Response, J NAT CANC, 92(23), 2000, pp. 1951-1952
Citation: Ah. Wu et al., Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer - Response, J NAT CANC, 92(1), 2000, pp. 78-78
Citation: Dv. Spicer et Mc. Pike, Future possibilities in the prevention of breast cancer - Luteinizing hormone-releasing hormone agonists, BREAST CA R, 2(4), 2000, pp. 264-267
Authors:
Formenti, S
Felix, J
Salonga, D
Danenberg, K
Pike, MC
Danenberg, P
Citation: S. Formenti et al., Expression of metastases-associated genes in cervical cancers resected in the proliferative and secretory phases of the menstrual cycle, CLIN CANC R, 6(12), 2000, pp. 4653-4657
Citation: Ah. Wu et al., A meta-analysis of soyfoods and risk of stomach cancer: The problem of potential confounders, CANC EPID B, 9(10), 2000, pp. 1051-1058
Citation: G. Ursin et al., Should women with a family history of breast cancer avoid use of oral contraceptives?, EPIDEMIOLOG, 11(5), 2000, pp. 615-616
Authors:
Lu, JJ
Zheng, Y
Kang, X
Yuan, JM
Lauchlan, SC
Pike, MC
Zheng, WX
Citation: Jj. Lu et al., Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer, GYNECOL ONC, 79(2), 2000, pp. 158-168
Authors:
Zheng, WX
Lu, JJ
Luo, F
Zheng, Y
Feng, YJ
Felix, JC
Lauchlan, SC
Pike, MC
Citation: Wx. Zheng et al., Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone, GYNECOL ONC, 76(1), 2000, pp. 80-88
Citation: Mc. Pike et Rk. Ross, Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer, STEROIDS, 65(10-11), 2000, pp. 659-664
Authors:
Probst-Hensch, NM
Pike, MC
McKean-Cowdin, R
Stanczyk, FZ
Kolonel, LN
Henderson, BE
Citation: Nm. Probst-hensch et al., Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight, BR J CANC, 82(11), 2000, pp. 1867-1870
Authors:
Stram, DO
Hankin, JH
Wilkens, LR
Pike, MC
Monroe, KR
Park, S
Henderson, BE
Nomura, AMY
Earle, ME
Nagamine, FS
Kolonel, LN
Citation: Do. Stram et al., Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles, AM J EPIDEM, 151(4), 2000, pp. 358-370
Citation: Ah. Wu et al., Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer - Response, J NAT CANC, 91(17), 1999, pp. 1512-1512
Authors:
Ursin, G
London, S
Stanczyk, FZ
Gentzschein, E
Paganini-Hill, A
Ross, RK
Pike, MC
Citation: G. Ursin et al., Urinary 2-hydroxyestrone/16 alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women, J NAT CANC, 91(12), 1999, pp. 1067-1072
Authors:
Makridakis, NM
Ross, RK
Pike, MC
Crocitto, LE
Kolonel, LN
Pearce, CL
Henderson, BE
Reichardt, JKV
Citation: Nm. Makridakis et al., Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA, LANCET, 354(9183), 1999, pp. 975-978